Cytovance Biologics

About:

Cytovance Biologics produces therapeutic proteins and antibodies from mammalian cell cultures and microbial fermentations.

Website: http://www.cytovance.com

Twitter/X: CBiologics

Top Investors: Great Point Partners, Monroe Capital

Description:

Cytovance Biologics is a full service CDMO specializing in cGMP production of therapeutic proteins & antibodies from mammalian cell culture (CHO), microbial fermentation (Ecoli), and transgenic processes. We offer cell line development, process development services, purification development, stability testing, and more from our FDA inspected, Oklahoma City state-of-the-art facilities.

Total Funding Amount:

$42.5M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Oklahoma City, Oklahoma, United States

Founded Date:

2005-01-01

Contact Email:

lbarish(AT)cytovance.com

Founders:

Number of Employees:

251-500

Last Funding Date:

2014-10-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai